ECOR - electroCore, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

electroCore, Inc.

150 Allen Road
Suite 201
Basking Ridge, NJ 07920
United States
973-290-0097
http://www.electrocore.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees91

Key Executives

NameTitlePayExercisedYear Born
Mr. Francis R. AmatoCEO & Director866.52kN/A1964
Mr. Joseph P. ErricoCo-Founder, Principal Investor & Director685.19kN/A1969
Dr. Peter S. StaatsSr. Exec. Advisor of Medical & Gov. Affairs463.73kN/A1964
Mr. Brian M. PosnerCFO & Corp. Sec.N/AN/A1962
Mr. Eric J. LieblerSr. VP of NeurologyN/AN/A1964
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

electroCore, Inc., a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, which is a handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.

Corporate Governance

electroCore, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.